Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector
Reexamination Certificate
2007-01-23
2007-01-23
Siew, Jeffrey (Department: 1642)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Reexamination Certificate
active
10366881
ABSTRACT:
A method of inhibiting proliferation of cells associated with a tumor in a subject which comprises administering to the subject a tumor cell proliferation amount of IGF-BP3, thereby inhibiting proliferation of the cells. An improved surgical method which comprises surgically resecting a tumor from a subject and administering to the subject an amount of a protein effective to inhibit metastasis of any tumor cells released in the subject's blood circulation during the surgical resection of the tumor.
REFERENCES:
patent: 5407913 (1995-04-01), Sommer et al.
patent: 5643867 (1997-07-01), Maack et al.
patent: 5840673 (1998-11-01), Buckbinder et al.
patent: 6124259 (2000-09-01), Delmage et al.
patent: 6303583 (2001-10-01), Kusunoki
patent: WO 98/32022 (1998-07-01), None
Taber's Cyclopedic Medical Dictionary, 1989, ed. by Clayton L. Thomas (F.A. Davis Company, Philadelphia, PA), p. 42.
Eschwege and Dumas, 1995, Haematogenous dissemination of prostatic epithelial cells during radical prostatectomy, Lancet 346(8989):1528-1530.
Sullivan et al., 2000, Regulation of expression of the multidrug resistance protein MRP1 by p53 in hujman prostate cancer cells, J. Clin. Invest. 105(9):1261-1267.
Saltus, New Surgery called less invasive for prostate patients, The Boston Globe (Jan. 26, 2001), Boston, MA.
Tortola et al., 1999, p53 and K-ras Gene Mutations Correlate With Tumor Aggressiveness But Are Not of Routine Prognostic Value in Colorectal Cancer, J. of Clin. Oncol. 17(5):1375-1381.
Davenport et al., 1992, Insulin-Like Growth Factor-Binding Protein-3 Proteolysis Is Induced after Elective Surgery, J. of Clin. Endocrinol. 75(2):590-595.
Allendorf et al., 1998, Increased tumor establishment and growth after open vs laproscopic bowel resection in mice, Surgical Endoscopy 12:1035-1038.
Allendorf, J. D.: Bessler, M.; Horvath, K. D.; Marvin, M. R.; Laird, D. A.; Whelan, R. L. Increased tumor establishment and growth after open vs laparoscopic surgery in mice may be related to differences in postoperative T-cell function,Surg. Endosc. 1999, 13, 233-235 (Exhibit 1).
Allendorf, J. D.; Bessler, M.; Horvath, K. D.; Marvin, M. R.; Laird, D. A.; Whelan, R. L. Increased tumor establishment and growth after open vs laparoscopic bowel resection in mice.Surg. Endosc. 1998, 12, 1035-1038 (Exhibit 2).
Allendorf, J. D.; Bessler, M.; Kayton, M. L.; Oesterling, S. D.; Treat, M. R.; Nowygrod, R.; Whelan, R. L. Increased tumor establishment and growth after laparotomy vs laparoscopy in a murine model.Arch. Surg. 1995, 130, 6, 649-653 (Exhibit 3).
Bang, P.; Fielder, P. J. Human pregnancy serum contains at least two distinct proteolytic activities with the ability to degrade insulin-like growth factor binding protein-3.Endocrinology1997, 138, 3912-3917 (Exhibit 4).
Cotterill, A. M.; Mendel, P.; Holly, J. M. P.; Timmins, A. G.; Camacho-Hübner, C.; Hughes, S. C. et al. The differential regulation of the circulating levels of the insulin-like growth factors and their binding proteins (IGFBP) 1, 2 and 3 after elective abdominal surgery.Clin. Endocrinol. 1996, 44, 91-101 (Exhibit 5).
Da Costa, M. L.; Redmond, P.; Bouchier-Hayes, D. J. The effect of laparotomy and laparoscopy on the establishment of spontaneous tumor metastases.Surgery1998, 124, 516-525 (Exhibit 6).
Davenport, M. L.; Isley, W. L.; Pucilowska, J. B.; Pemberton, L. B.; Lyman, B.; Underwood, L. E.; Clemmons, D. R. Insulin-like growth factor-binding protein-3 proteolysis is induced after elective surgery.J. Clin. Endocrinol. Metab. 1992, 75, 590-595 (Exhibit 7).
Fanayan, S.; Firth, S. M.; Butt, A. J.; Baxter, R. C. Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-beta (TGF-beta) and the type II TGF-beta receptor.J. Biol. Chem. 2000, 275, 39146-39151 (Exhibit 8).
Kansra, S.; Ewton, D. Z.; Wang, J.; Friedman, E. IGFBP-3 mediates TGF bet 1 proliferative response in colon cancer cells.Int. J. Cancer2000, 87, 373-378 (Exhibit 9).
Lee, S. W.; Gleason, N. R.; Stapleton, G. S.; Zhai, C.; Huang, E. H.; Bessler, M.; Whelan, R. L. Increased platelet-derived growth factor (PDGF) release after laparotomy stimulates systemic tumor growth in mice.Surg. Endosc. 2001, 15, 981-985 (Exhibit 10).
Lee, S. W.; Gleason, N. R.; Southall, J. C.; Allendorf, J. D.; Blanco, I.; Huang, E. H et al. A serum-soluble factor(s) stimulates tumor growth following laparotomy in a murine model.Surg. Endosc. 2000, 14, 490-494 (Exhibit 11).
Lee, S. W.; Southall, J. C.; Allendorf, J. D.; Bessler, M.; Whelan, R. L. Tumor proliferative index is higher in mice undergoing laparotomy vs. CO2pneumoperitoneum.Dis. Colon Rectum1999, 42, 477-481 (Exhibit 12).
Lee, S. W.; Gleason, N. R.; Ssenymanturo, K.; Woodring, J.; Bessler, M.; Whelan, R. L. Colon cancer tumor proliferative index is higher and tumor cell death rate is lower in mice undergoing laparotomy vs. insufflation.Surg. Endosc. 1998, 12, 514 (Exhibit 13).
MacDonald, R. G.; Schaffer, B. S.; Kang, I. J.; Hong, S. M.; Kim, E. J.; Park, J. H. Growth inhibition and differentiation of the human colon carcinoma cell line, Caco-2, by constitutive expression of insulin-like growth factor binding protein-3.J. Gastroenterol. Hepatol. 1999, 14, 72-78 (Exhibit 14).
Milsom, J. W.; Bohm, B.; Hammerhofer, K. A.; Fazio, V.; Steiger, E.; Elson, P. A prospective, randomized trial comparing laparoscopic versus conventional techiniques in colorectal cancer surgery: a preliminary report.J. Am. Coil. Surg. 1998, 187, 46-54 (Exhibit 15).
Murakami, K.; Matsuura, T.; Hasumura, S.; Nagamori, S.; Yamada, Y.; Saiki, I. Involvement of insulin-like growth factor binding protein-3 in the retinoic acid receptor-alpha-mediated inhibition of hepatocellular carcinoma cell proliferation.Cancer Lett. 2000, 151, 63-70 (Exhibit 16).
Pidgeon, G. P.; Harmey, J. H.; Kay, E.; Da Costa, M.; Redmond, H. P.; Bouchier-Hayes, D. J. The role of endotoxin/lipopolysaccharide in surgically induced tumour growth in a murine model of metastatic disease.Br. J. Cancer1999, 81, 1311-1317 (Exhibit 17).
Rajah, R.; Valentinis, B.; Cohen, P. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-β1 on programmed cell death through a p53- and IGF-independent mechanism.J. Biol. Chem. 1997, 272, 12181-12188 (Exhibit 18).
Shiromizu, A.; Suematsu, T.; Yamaguchi, K; Shiraishi, N.; Adachi, Y.; Kitano, S. Effect of laparotomy and laparoscopy on the establishment of lung metastasis in a murine model.Surgery2000, 128, 799-805 (Exhibit 19).
Southall, J. C.; Lee, S. W.; Allendorf, J. D.; Bessler, M.; Whelan, R. L. Colon adenocarcinoma and B-16 melanoma grow larger following laparotomy vs. pneumoperitoneum in a murine model.Dis Colon Rectum1998, 41, 564-569 (Exhibit 20).
Taylor, L.D., et al. A transgenic mouse that expresses a diversity of human sequence heavy and light chain immunoglobulins.Nucl. Acids Res. 1992, 20, 6287-6295 (Exhibit 21).
Yu, H.; Rohan, T. Role of the Insulin-like Growth Factor family in cancer development and progression.Review J. Natl. Cancer Inst. 2000, 92, 1472-1489 (Exhibit 22).
Notification of Transmittal of the International Search Report issued by the International Searching Authority on Dec. 28, 2004 in connection with PCT International Application No. PCT/US03/04315, filed Feb. 13, 2003.
Oct. 21, 2005 Notification of Transmittal of International Preliminary Examination Report issued by the International Preliminary Examining Authority in connection with related International Application No. PCT/US03/04315.
Kirman Irena
Whelan Richard L.
Cooper & Dunham LLP
Joyce Catherine
Siew Jeffrey
The Trustees of Columbia University in the City of New York
White John P.
LandOfFree
Use of insulin-like growth factor binding protein 3... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of insulin-like growth factor binding protein 3..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of insulin-like growth factor binding protein 3... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3757900